Title : Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period - Kadowaki_2017_Expert.Opin.Pharmacother_18_1291 |
Author(s) :
Kadowaki T , Kondo K , Sasaki N , Miyayama K , Yokota S , Terata R , Gouda M |
Ref :
Expert Opin Pharmacother , 18 :1291 , 2017 |
Abstract : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291 |
ESTHER : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291 |
PubMedSearch : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291 |
PubMedID: 28741385 |